SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021943
Filing Date
2022-11-03
Accepted
2022-11-03 16:38:17
Documents
63
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nuvb-20220930.htm   iXBRL 10-Q 3576442
2 EX-31.1 nuvb-ex31_1.htm EX-31.1 22000
3 EX-31.2 nuvb-ex31_2.htm EX-31.2 22100
4 EX-32.1 nuvb-ex32_1.htm EX-32.1 11674
5 EX-32.2 nuvb-ex32_2.htm EX-32.2 9975
  Complete submission text file 0000950170-22-021943.txt   11821859

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nuvb-20220930_pre.xml EX-101.PRE 309065
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nuvb-20220930_lab.xml EX-101.LAB 406978
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nuvb-20220930_def.xml EX-101.DEF 182876
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nuvb-20220930.xsd EX-101.SCH 51304
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nuvb-20220930_cal.xml EX-101.CAL 52970
57 EXTRACTED XBRL INSTANCE DOCUMENT nuvb-20220930_htm.xml XML 2788336
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39351 | Film No.: 221358650
SIC: 2834 Pharmaceutical Preparations